STAAR Surgical Company
STAA
$18.03
$0.150.84%
NASDAQ
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Net Income | -442.97% | 35.25% | 320.99% | -143.05% | 61.01% |
| Total Depreciation and Amortization | 35.17% | 15.44% | 23.04% | 2.06% | -9.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.31% | 1.70% | 46.49% | 173.09% | -73.86% |
| Change in Net Operating Assets | 239.84% | 38.02% | -275.44% | -17.75% | 193.45% |
| Cash from Operations | -83.18% | 136.65% | -148.03% | -32.18% | 635.05% |
| Capital Expenditure | 8.12% | 0.08% | -19.88% | -68.46% | 66.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.53% | -101.01% | -167.47% | -16.09% | -37.87% |
| Cash from Investing | 44.68% | -70.51% | -227.68% | -27.74% | -29.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2.38% | 0.00% | -5.00% | 0.00% | -2.56% |
| Issuance of Common Stock | -97.59% | 345.43% | -93.01% | 1,205.15% | -94.38% |
| Repurchase of Common Stock | -- | 100.00% | 86.41% | -122,800.00% | 99.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -106.81% | 890.80% | -95.98% | 1,005.18% | -94.84% |
| Foreign Exchange rate Adjustments | -184.96% | 414.24% | 64.78% | -207.95% | 469.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.03% | 7.92% | -176.24% | -26.29% | 69.86% |